| [1] |
Launay-Vacher V, Oudard S, Janus N, et al. Prevalence of Renal Insufficiency in cancer patients and implications for anticancer drug management: the renal insufficiency and anticancer medications (IRMA)study [J]. Cancer, 2007, 110(6): 1376-1384.
|
| [2] |
Hong J, Lee S, Chun G, et al. Baseline renal function as a prognostic indicator in patients with newly diagnosed diffuse large B-cell lymphoma [J]. Blood Res, 2016, 51(2): 113-121.
|
| [3] |
Yang Y, Li HY, Zhou Q, et al. Renal function and all-cause mortality risk among cancer patients [J]. Medicine (Baltimore), 2016, 95(20): e3728.
|
| [4] |
Collins AJ, Foley RN, Chavers B, et al. United States Renal Data System 2011 Annual Data Report: Atlas of chronic kidney disease & end-stage renal disease in the United States [J]. Am J Kidney Dis, 2012, 59(1 Suppl 1): e1-e420.
|
| [5] |
Pabla N, Dong Z. Cisplatin nephrotoxicity: mechanisms and renoprotective strategies [J]. Kidney Int, 2008, 73(9): 994-1007.
|
| [6] |
钱超，陆清昀，张晓春．癌症患者顺铂化疗相关肾毒性的临床进展[J]．实用癌症杂志，2014 ，29(5): 607-608.
|
| [7] |
王海燕．肾脏病学[M]．第3版．北京：人民卫生出版社，2009：1599-1602.
|
| [8] |
Yamazaki T, Suzuki H, Tobe T, et al. Prostate adenocarcinoma producing syndrome of inappropriate secretion of antidiuretic hormone [J]．Int J Urol, 2001, 8(9): 513-516.
|
| [9] |
闫菲菲．铂类抗肿瘤药物相关肾损伤作用机制的研究进展[J]．中国肺癌杂志，2015，18(9): 580-586.
|
| [10] |
刘芳，付平．恶性肿瘤肾损害[J]．中国实用内科杂志，2011，31(2): 100-102.
|
| [11] |
de Oliveira Filgueira PH, Vasconcelos LF, da Silva GB. Paraneoplastic syndromes and the kidney [J]. Saudi J Kidney Dis Transpl, 2010, 21(2): 222-231.
|
| [12] |
Cagnoli L. Solid tumors and paraneoplastic glomerulonephritis [J]. G Ital Nefrol, 2010, 27(Suppl 50): S51-S57.
|
| [13] |
Harper L, Adu D. Glomerulonephritis and non-Hodgkin lymphoma [J]. Nephrol Dial Transplant, 1997, 12(7): 1520-1525.
|
| [14] |
李世军，陈惠萍，陈樱花，等．非霍奇金淋巴瘤相关肾脏损害[J]．肾脏病与透析肾移植杂志，2013，22(6): 526-534.
|
| [15] |
Zhang K, Lai Y, Axelrod R, et al. Modelling the overall survival of patients with advanced-stage non-small cell lung cancer using data of routine laboratory tests [J]. Int J Cancer, 2015, 136(2): 382-391.
|
| [16] |
Sohal DP, Shrotriya S, Glass KT, et al. Predicting early mortality in resectable pancreatic adenocarcinoma: a cohort study [J]. Cancer, 2015, 121(11): 1779-1784.
|
| [17] |
朱楠，刘东伟，郭佳．血清抗PLA2R抗体在特发性膜性肾病中的临床应用价值[J]．实用医学杂志，2017，33(4): 619-622.
|
| [18] |
李世军，秦卫松，张明超，等．肿瘤相关膜性肾病：抗足细胞自身抗体与肾组织IgG亚型的检测[J]．肾脏病与透析肾移植杂志，2011，20(1): 12-17.
|
| [19] |
张亚东，解小成，房松，等．大黄甘草汤治疗抗肿瘤药物性肾损害1 0例[J]. 中医杂志，2004，45(4): 259.
|
| [20] |
刘研新，余彦，王蓓，等．鹿角灵芝胶囊的抗肿瘤活性及对顺铂所致肾损伤的保护作用[J]．华西药学杂志，2008, 23(5): 564-566.
|